产品说明书
Masoprocol
 |
同义名 : | meso-Nordihydroguaiaretic acid;meso-NDGA |
| CAS号 : | 27686-84-6 | |
| 货号 : | A914482 | |
| 分子式 : | C18H22O4 | |
| 纯度 : | 98+% | |
| 分子量 : | 302.365 | |
| MDL号 : | MFCD00866548 | |
| 存储条件： |
粉末 Sealed in dry,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 105 mg/mL(347.26 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Masoprocol is an antineoplastic drug used to treat skin growths caused by sun exposure. A form of nordihydroguaiaretic acid that is taken by mouth is being studied in the treatment of prostate cancer. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00259818 | Cancer | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Premiere Oncology of Arizona Scottsdale, Arizona, United States United States, New York Albert Einstein College of Medicine Bronx, New York, United States United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States 收起 << |
| NCT00664586 | Refractory Solid Tumors ... 展开 >> Lymphoma 收起 << | Phase 1 | Terminated(Funding constraints... 展开 >>) 收起 << | - | United States, Tennessee ... 展开 >> The Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 收起 << |
| NCT00664677 | Leukemias Acu... 展开 >>te Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Adult T Cell Leukemia (ATL) Chronic Myeloid Leukemia (CML-BP) Chronic Lymphocytic Leukemia (CLL) Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) 收起 << | Phase 1 | Terminated(Funding constraints... 展开 >>) 收起 << | - | United States, North Carolina ... 展开 >> UNC, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.31mL 0.66mL 0.33mL |
16.54mL 3.31mL 1.65mL |
33.07mL 6.61mL 3.31mL |
| 参考文献 |
|---|